The largest database of trusted experimental protocols

Vevo 770 high resolution micro imaging system

Manufactured by Fujifilm
Sourced in Canada

The Vevo 770 High-Resolution Micro-Imaging System is a state-of-the-art laboratory equipment designed for high-resolution in vivo imaging. The system utilizes advanced ultrasound technology to capture detailed images and measurements of small animals and samples with high spatial resolution.

Automatically generated - may contain errors

13 protocols using vevo 770 high resolution micro imaging system

1

Cardiac Function Evaluation After Surgery

Check if the same lab product or an alternative is used in the 5 most similar protocols
On the 28th day after surgery, the cardiac function was evaluated using the Vevo 770 high-resolution microimaging system (VisualSonics, Toronto, Canada) as previously described.[10 (link)] The ultrasonic probe frequency was 30 HZ with an ultrasound measurement under the guidance of a two-dimensional image. All test images were used the same ultrasound parameters, and each image was measured at least five consecutive cycles.
+ Open protocol
+ Expand
2

Antitumor Efficacy of HTiO2 NPs in SCC7 Liver Tumor

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the antitumour efficacy of HTiO2 NPs in the SCC7 liver tumour model, tumour-bearing mice were prepared as described above. After 3 days, HTiO2 NPs were injected into the tail vein of the mice and the mice were divided into three groups: (a) non-treated (3 days), (b) non-treated (10 days), and (c) HTiO2 NPs + US (10 days). Tumour-bearing mice were treated with US 3 h after intravenous injection. US treatment for liver tumour tissue was performed over a total period of 330 seconds (power: 30 W, frequency: 1.5 MHz, duty cycle: 10%, pulse repetition frequency: 1 Hz, time: 30 seconds, interval: 2 mm). In vivo ultrasound 3D rendering images were obtained using a Vevo770® High-Resolution Micro-Imaging System (Visualsonics, Toronto, Canada) equipped with a RMV 706 probe (frequency: 40 MHz, power: 100%, RF cycles: 1, sound speed: 1540 m/second, depth: 1 mm, FOV: 10 × 10 mm, frame rate: 11 Hz, 3D step size: 0.102 mm). Results for tumour volume inhibition were obtained using the OV-100 small-animal imaging system. Tumour volumes were calculated as a × b2 × 0.54, where a is the largest and b the smallest diameter. Ex vivo images of major organ images were also obtained using the OV-100.
+ Open protocol
+ Expand
3

Cardiac Geometry and Function Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vivo cardiac geometry and function was assessed using a Vevo 770 high‐resolution micro‐imaging system (VisualSonics), as previously described.14 Two weeks after TAC surgery, two‐dimensional and M‐mode imaging were performed. The left ventricle inner diameter during diastole (LVIDd) and left ventricle anterior wall thickness during diastole (LVAWd) of mouse hearts were measured. In addition, left ventricular ejection fraction (EF) and fractional shortening (FS) were evaluated.
+ Open protocol
+ Expand
4

Echocardiography Assessment of Cardiac Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Echocardiography was performed blindly with the Vevo 770 High-Resolution Micro-Imaging System (VisualSonics) with a 15-MHz linear-array ultrasound transducer. The left ventricle was assessed in both parasternal long-axis and short-axis views at a frame rate of 120 Hz. End-systole or end-diastole were defined as the phases in which the left ventricle appeared the smallest and largest, respectively, and used for ejection-fraction measurements. To calculate the shortening fraction, left-ventricular end-systolic and end-diastolic diameters were measured from the left-ventricular M-mode tracing with a sweep speed of 50 mm/s at the papillary muscle. B-mode was used for two-dimensional measurements of end-systolic and end-diastolic dimensions. Imaging and calculations were done by an individual who was blinded to the treatment applied to each animal and code was broken only after all data acquired.
+ Open protocol
+ Expand
5

Histological and Echocardiographic Analysis of Cardiac Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Histological studies were performed as described previously [20 (link)]. Briefly, cardiac tissues were paraffin embedded and sectioned at a thickness of 5 μm for hematoxylin and eosin staining. Hematoxylin and eosin staining were performed according to the manufacturer’s protocols. Echocardiography to assess cardiac function was performed in the mice using a Vevo 770 High-Resolution Micro-Imaging System (Visual Sonics Inc, Toronto, Canada). Mice were anesthetized with 1% isofluorane/ oxygen administered through inhalation. M-mode and two-dimensional measurements were performed as described previously [21 (link)].
+ Open protocol
+ Expand
6

Echocardiographic Assessment of Left Ventricular Dimensions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Echocardiography was performed with the Vevo 770 High-Resolution Micro-Imaging System (VisualSonics, Toronto, ON, Canada) with a 15-MHz linear array ultrasound transducer. The LV was assessed in both parasternal long-axis and short-axis views at a frame rate of 120 Hz. End-systole or end-diastole was defined as the phase in which the smallest or largest area of LV, respectively, was obtained. Left ventricular end-systolic diameter (LVDS) and left ventricular end-diastolic diameter (LVDD) were measured from the LV M-mode tracing with a sweep speed of 50 mm/sec. at the papillary muscle level.
+ Open protocol
+ Expand
7

Cardiovascular Measurements in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cardiovascular measurements, a Vevo770 High-Resolution Micro-Imaging System (VisualSonics, Toronto, ON, Canada) with 30-MHz probe (RMV-707B) was used as previously described.35 (link) Male mice were anesthetized with 3–4% isoflurane, and then switched to 1–1.5% isoflurane mixed with 100% oxygen. At the level of the papillary muscles, two-dimensional-guided M-mode echocardiography was obtained from anterior (+septum) and posterior walls. Mouse systolic blood pressure measurement was recorded by Mouse Blood Pressure System (MRBP-MMC, IITC Life Science Inc, CA, USA) through tail-cuff method after the mouse was trained for 2–3 days until it was comfortable and quiet in the nose cone animal holder. Mouse diastolic blood pressure was calculated by the software MRBP Monitor Version 1.59 (MRBP-MMC, IITC Life Science Inc, CA, USA).
+ Open protocol
+ Expand
8

Echocardiography Measurement of Cardiac Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
The data of echocardiography was obtained with the Vevo 770 High-Resolution Micro-Imaging System (VisualSonics, Canada) using a 30-MHz image transducer. At first, preparing the chest skin of the experimental mice and anesthetized the mice with 1.25% tribromoethyl aicolaol. Proceed the Echo under the mice physiology condition of ∼500 beats per min heart rate to guarantee the accuracy of cardiac function measurement. Then, the mice were fixed on the operating table (37°C) in a supine position. Two-dimensional image was obtained and collected parameters include left ventricular ejection fraction (EF), left ventricular fractional shortening (FS), left ventricular end diastolic anterior wall thickness (LVAWd), and left ventricular end diastolic posterior wall dimension (LVPWd).
+ Open protocol
+ Expand
9

Echocardiographic Assessment of Cardiac Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Echocardiography was performed blindly using the Vevo 770 High-Resolution Micro-Imaging System (Visual Sonics) with a 15 MHz linear-array ultrasound transducer. The left ventricle was assessed in both parasternal long-axis and short-axis views at a frame rate of 120 Hz. End-systole or end-diastole were defined as the phases in which the left ventricle appeared the smallest and largest, respectively, and used for ejection-fraction measurements. To calculate the shortening fraction, left-ventricular end-systolic and end-diastolic diameters were measured from the left-ventricular M-mode tracing with a sweep speed of 50 mm/s at the papillary muscle as previously reported47 (link). Imaging and calculations were done by an individual who was blinded to the treatment applied to each animal and this code was broken only after all data was acquired. At the end of the experiments, Animals were sacrificed by barbiturate overdose (150 mg/kg pentobarbital sodium, intraperitoneal injection) and cervical dislocation, and their hearts harvested for histological studies.
+ Open protocol
+ Expand
10

Murine Echocardiography for Cardiac Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse transthoracic echocardiograms were performed as previously
described (Mohamed et al., 2016 ).
Briefly, mice were anesthetized with isoflurane, placed on a heating pad,
and ventral fur shaved with clippers. Echocardiography was performed with
the Vevo 770 High-Resolution Micro-Imaging System (VisualSonics) with a
15-MHz linear-array ultrasound transducer. The left ventricle was assessed
in both parasternal long-axis and short-axis views at a frame rate of
120?Hz. End-systole or end-diastole were defined as the phases in which the
left ventricle appeared the smallest and largest, respectively, and used for
ejection-fraction measurements. To calculate the shortening fraction, left
ventricular end-systolic and end-diastolic diameters were measured from the
left ventricular M-mode tracing with a sweep speed of 50 mm/s at the
papillary muscle. Bmode was used for two-dimensional measurements of
end-systolic and end-diastolic dimensions. The echocardiographer was blinded
to the study groups.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!